Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
October 22, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 22, 2024 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
October 16, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 12, 2024 EFFECT

EFFECT

View HTML
September 10, 2024 CORRESP

CORRESP

View HTML
September 9, 2024 UPLOAD

UPLOAD

View HTML
September 3, 2024 S-3

Simplified registration form

View HTML
August 8, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 8, 2024 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 11, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us